New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most

Key Points:

• New breakthrough therapies for sickle cell disease are on the horizon.
• These therapies have the potential to improve the lives of millions of people suffering from this genetic disorder.
• However, access to these treatments will likely be limited in low-income countries and regions where sickle cell disease is most prevalent.
• The high cost of these therapies is a major barrier for patients in resource-limited settings.
• Furthermore, the lack of infrastructure and trained healthcare professionals in these areas poses additional challenges for delivering these therapies effectively.
• There is a need for innovative solutions to ensure that these life-saving treatments reach those who need them the most.

HOT TAKE:

It’s a bittersweet situation when groundbreaking treatments for sickle cell disease are within our grasp, but those who need them the most might not be able to access them. The high cost and lack of infrastructure in low-income countries make it difficult for patients to benefit from these therapies. It’s time for us to come up with creative solutions and make healthcare more equitable, so that no one is left behind in the race for better health. After all, laughing is good for your health, but let’s not leave anyone out of the joke!

Original article:https://www.nytimes.com/2023/12/08/health/casgevy-lyfgenia-sickle-cell-africa.html